Keratin 1: A negative regulator of inflammation and potential treatment for pulmonary arterial hypertension
Open Access
- 6 December 2020
- journal article
- editorial
- Published by Wiley in Acta Physiologica
- Vol. 231 (2) , e13594
Abstract
This study by Zhang et al. entitled “Keratin 1 attenuates hypoxic pulmonary artery hypertension through suppressing pulmonary artery media smooth muscle expansion” is presented in a recent edition of Acta Physiologica [1]. Leading up to this research were at least three key ideas: 1) that keratin 1 (Krt1) is considered the gatekeeper of the skin’s innate immune response for its important regulatory role of both local and systemic inflammation [2], 2) that inflammation is central to the pathogenesis of pulmonary arterial hypertension (PAH) [3], and 3) that keratins can promote apoptosis of smooth muscle cells derived from human atherosclerotic lesions [4].Keywords
This publication has 6 references indexed in Scilit:
- Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial HypertensionCirculation Research, 2014
- Keratin intermediate filament proteins – novel regulators of inflammation and immunity in skinJournal of Cell Science, 2012
- Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epitheliaJournal of Anatomy, 2009
- Transcription factor YY1: structure, function, and therapeutic implications in cancer biologyOncogene, 2005
- Nitric oxide regulates synthesis of gene products involved in keratinocyte differentiation and ceramide metabolismEuropean Journal of Cell Biology, 2004
- Phosphorylation of cytokeratin 8 and 18 in human vascular smooth muscle cells of atherosclerotic lesions and umbilical cord vesselsBasic Research in Cardiology, 2001